TLR2 mediates immunity to experimental cysticercosis

International Journal of Biological Sciences

Volumn 7, Issue 9, 2011, Pages 1323-1333

  Reyes, José L ^a   González, Marisol I ^a   Ledesma Soto, Yadira ^a   Satoskar, Abhay R ^b   Terrazas, Luis I ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Alternatively activated macrophages; Cysticercosis; Taenia crassiceps; TLR2

Indexed keywords

FUNGI; MUS; TAENIA; TAENIA CRASSICEPS; VERMES;

EID: 81255195726     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.1323     Document Type: Article

References (50)

1. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature, 2007. 449(7164): 819-26.
2. Kawai T and Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol, 2009. 21(4): 317-37.
3. Bhattacharya P, et al. Arabinosylated lipoarabinoman-nan-mediated protection in visceral leishmaniasis through up-regulation of toll-like receptor 2 signaling: an im-munoprophylactic approach. J Infect Dis, 2010. 202(1): 145-55.
4. Campos M. A, et al. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypano-soma cruzi in mice lacking functional myeloid differentiation factor 88. Immunol J, 2004. 172(3): 1711-8.
5. Ropert C and Gazzinelli R.T. Regulatory role of Toll-like re-ceptor 2 during infection with Trypanosoma cruzi. J Endotoxin Res, 2004. 10(6): 425-30.
6. Becker I, et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol, 2003. 130(2): 65-74.
7. Debierre-Grockiego F, et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. Immunol J, 2007. 179(2): 1129-37.
8. Krishnegowda G, et al. Induction of proinflammatory respons-es in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glyco-sylphosphatidylinositol (GPI) structural requirement, and reg-ulation of GPI activity. J Biol Chem, 2005. 280(9): 8606-16.
9. Bansal K, et al. Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses. J Biol Chem, 2010. 285(47): 36511-22.
10. Jung T. Y, et al. Ursolic acid isolated from Uncaria rhyncho-phylla activates human dendritic cells via TLR2 and/or TLR4 and induces the production of IFN-gamma by CD4+ naive T cells. Eur Pharmacol J, 2010. 643(2-3): 297-303.
11. Makino M, et al. Innate immunity in DNA vaccine with Toxo-plasma gondii-heat shock protein 70 gene that induces activa-tion DC and Th1 polarization. Vaccine, 2011. 29(10): 1899-905.
12. Shimizu T, Kida Y, and Kuwano K. Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear fac-tor-kappaB through toll-like receptors 1 and 2. Immunology, 2007. 121(4): 473-83.
13. Azuma M, et al. The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation. PLoS One, 2010. 5(9): e12550.
14. van der Kleij D, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like recep-tor 2 and affects immune polarization. J Biol Chem, 2002. 277(50): 48122-9.
15. Koster B and Strand M. Schistosoma mansoni: Sm23 is a transmembrane protein that also contains a glycosylphospha-tidylinositol anchor. Arch Biochem Biophys, 1994. 310(1): 108-17.
16. van Die I, et al. Structural and functional analysis of glyco-sphingolipids of Schistosoma mansoni. Methods Enzymol, 2010. 480: 117-40.
17. Magalhaes K. G, et al. Schistosomal-derived lysophosphatidyl-choline are involved in eosinophil activation and recruitment through Toll-like receptor-2-dependent mechanisms. J Infect Dis, 2010. 202(9): 1369-79.
18. Lopez-Marin L. M, et al. Structure and antigenicity of the major glycolipid from Taenia solium cysticerci. Mol Biochem Parasi-tol, 2002. 119(1): 33-42.
19. Mamuti W, et al. Recent advances in characterization of Echi-nococcus antigen B. Parasitol Int, 2006. 55: S57-62.
20. Gordon S and Martinez F.O. Alternative activation of macro-phages: mechanism and functions. Immunity, 2010. 32(5): 593-604.
21. Reyes J. L and Terrazas L.I. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite im-munology, 2007. 29(12): 609-19.
22. Bowcutt R, et al. Arginase-1-expressing macrophages are dis-pensable for resistance to infection with the gastrointestinal helminth Trichuris muris. Parasite immunology, 2011. 33(7): 411-20.
23. Herbert D. R, et al. IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schisto-somiasis. Journal of immunology, 2008. 181(10): 7214-20.
24. Terrazas L. I, et al. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. International journal for parasit-ology, 2005. 35(13): 1349-58.
25. Reyes J. L, et al. Early removal of alternatively activated mac-rophages leads to Taenia crassiceps cysticercosis clearance in vivo. International journal for parasitology, 2010. 40(6): 731-42.
26. Terrazas L. I, et al. Shift from an early protective Th1-type im-mune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). Parasitol J, 1998. 84(1): 74-81.
27. Terrazas L. I, et al. Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps. Parasitol Res, 1999. 85(2): 135-41.
28. Rodriguez-Sosa M, et al. Cutting edge: susceptibility to the larval stage of the helminth parasite Taenia crassiceps is medi-ated by Th2 response induced via STAT6 signaling. Immunol J, 2002. 168(7): 3135-9.
29. Ishida M. M, et al. Helminth antigens (Taenia solium, Taenia crassiceps, Toxocara canis, Schistosoma mansoni and Echino-coccus granulosus) and cross-reactivities in human infections and immunized animals. Acta Trop, 2003. 89(1): 73-84.
30. Arruda G. C, et al. Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for the serodiagnosis of neuro-cysticercosis. Trop Med Int Health, 2005. 10(10): 1005-12.
31. Baumeister S, et al. Comparative serological reactivity of Taenia crassiceps, Taenia solium and Taenia saginata metacestode neutral glycolipids to infection serum from Taenia cras-siceps-infected mice. Mol Biochem Parasitol, 1992. 53(1-2): 53-61.
32. Goh F, et al. Selective induction of the Notch ligand Jagged-1 in macrophages by soluble egg antigen from Schistosoma man-soni involves ERK signalling. Immunology, 2009. 127(3): 326-37.
33. van Riet E, et al. Combined TLR2 and TLR4 ligation in the context of bacterial or helminth extracts in human monocyte derived dendritic cells: molecular correlates for Th1/Th2 po-larization. Immunol BMC, 2009. 10: 9.
34. Vanhoutte F, et al. Toll-like receptor (TLR)2 and TLR3 sensing is required for dendritic cell activation, but dispensable to con-trol Schistosoma mansoni infection and pathology. Microbes Infect, 2007. 9(14-15): 1606-13.
35. Reyes J. L, et al. Differential response of antigen presenting cells from susceptible and resistant strains of mice to Taenia cras-siceps infection. Infect Genet Evol, 2009. 9(6): 1115-27.
36. Yokota S, Okabayashi T, and Fujii N. The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection. Mediators Inflamm, 2010. 2010: 184328.
37. Roeder A, et al. Toll-like receptors and innate antifungal re-sponses. Trends Microbiol, 2004. 12(1): 44-9.
38. Rodriguez-Sosa M, et al. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun, 2003. 71(3): 1247-54.
39. Rodriguez-Sosa M, et al. Altered T helper responses in CD40 and interleukin-12 deficient mice reveal a critical role for Th1 responses in eliminating the helminth parasite Taenia cras-siceps. Int Parasitol J, 2003. 33(7): 703-11.
40. Rodriguez-Sosa M, et al. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infect Immun, 2002. 70(7): 3656-64.
41. Terrazas L. I, et al. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Int Parasitol J, 2005. 35(13): 1349-58.
42. He Y, et al. Recombinant Ov-ASP-1, a Th1-biased protein ad-juvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells. Immunol J, 2009. 182(7): 4005-16.
43. Mishra B. B, et al. MyD88-deficient mice exhibit decreased par-asite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis. Infect Immun, 2009. 77(12): 5369-79.
44. Jorge I Alvarez; Bibhuti B Mishra; Uma Mahesh Gundra; Pramod K Mishra; Judy M Teale. Mesocestoides corti intracranial infection as a murine model for neurocysticercosis. Para-sitology 2010; 137(3): 359-72.
45. Verma A, et al. Toll-like receptor 4 polymorphism and its asso-ciation with symptomatic neurocysticercosis. J Infect Dis, 2010. 202(8): 1219-25.
46. Rodriguez-Sosa M, et al. A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia cras-siceps. Infect Immun, 2004. 72(8): 4552-60.
47. Zhang M, et al. Toll-like receptor (TLR) 2 and TLR4 deficiencies exert differential in vivo effects against Schistosoma japonicum. Parasite Immunol, 2011. 33(4): 199-209.
48. Dissanayake S and Shahin A. Induction of interferon-gamma by Taenia crassiceps glycans and Lewis sugars in naive BALB/c spleen and peritoneal exudate cells. Molecular immunology, 2007. 44(7): 1623-30.
49. Uddin J, et al. Mechanisms regulating monocyte CXCL8 secre-tion in neurocysticercosis and the effect of antiparasitic therapy. Journal of immunology, 2010. 185(7): 4478-84.
50. Mills G. L, Taylor D. C, and Williams J.F. Lipid composition of metacestodes of Taenia taeniaeformis and lipid changes during growth. Mol Biochem Parasitol, 1981. 3(5): 301-18.